Feasibility and acceptability of a mental health screening tool and training programme in the youth alcohol and other drug (AOD) sector

References

• Kandel D B, Johnson J G, Bird H R, et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry 1999; 38: 693–699
   PubMed Web of Science ®Google Scholar
• Kessler R, Crum R M, Warner L A, Nelson C B, Schulenberg J, Anthony J. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313–321
   PubMed Web of Science ®Google Scholar
• Lewinsohn P M, Hops H, Roberts R E, et al. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993; 102: 133–144
   PubMed Web of Science ®Google Scholar
• Bukstein O G, Glancy L G, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 1992; 31: 1041–1045
   PubMed Web of Science ®Google Scholar
• Kramer T L, Robbins J M, Phillips S D, Miller T L, Burns B J. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry 2003; 42: 1318–1326
   PubMed Web of Science ®Google Scholar
• Clark D A, Pollock N K, Bukstein O G, Mezzich A C, Bromberger J, Donovan J. Gender and comorbid psychopathology in adolescents in alcohol dependence. J Am Acad Child Adolesc Psychiatry 1997; 36: 1195–1203
   PubMed Web of Science ®Google Scholar
• Lubman D I, Allen N B, Rogers N, Cementon E, Bonomo Y. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord, in press
   Google Scholar
• DiMileo L. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry 1989; 146: 1212–1214
   PubMed Web of Science ®Google Scholar
• Fridell M, Hesse M. Psychiatric severity and mortality in substance abusers a 15-year follow-up of drug users. Addict Behav 2006; 31: 559–565
   PubMed Web of Science ®Google Scholar
• King R D, Gaines L S, Lambert E W, Summerfelt W T, Bickman L. The co-occurrence of psychiatric substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res 2000; 27: 417–430
   PubMed Web of Science ®Google Scholar
• Kavanagh D J, Mueser K T, Baker A. Management of comorbidity. Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment, M Teesson, H Proudfoot. Commonwealth of Australia, Sydney 2003; 78–120
   Google Scholar
• Hides L, Elkins K, Catania L S, Mathias S, Kay-Lambkin F, Lubman D I. Feasibility and outcomes of an innovative cognitive-behavioural skill training programme for co-occurring disorders in the youth alcohol and other grug (AOD) sector. Drug Alcohol Rev 2007; 26: 517–523
   PubMed Web of Science ®Google Scholar
• Hides L, Lubman D I, Devlin H, et al. The reliability and validity of K10 and PHQ amongst injecting drug users. Aust NZ J Psychiatry 2007; 41: 166–168
   PubMed Web of Science ®Google Scholar
• Kavanagh D J, Baker A, Teesson M. Co-morbidity of mental disorders and substance misuse: introduction. Drug Alcohol Rev 2004; 23: 405–406
   PubMed Web of Science ®Google Scholar
• Roche A M, Pollard Y. Improved services for people with drug and alcohol problems and mental illness: assisting alcohol and other drugs (AOD) non-government organisations to better respond to people with co-morbid AOD and mental health issues. National Centre for Education and Training on Addiction (NCETA), Flinders University, Adelaide 2006
   Google Scholar
• Cottler L B, Grant B F, Blaine J, et al. Concordance of the DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend 1997; 47: 195–205
   PubMed Web of Science ®Google Scholar
• Kranzler H R, Kadden R M, Babor T F, Tennen H. Validity of the SCID in substance abuse patients. Addiction 1996; 91: 859–868
   PubMed Web of Science ®Google Scholar
• Dawe S, Loxton N, Hides L, Kavanagh D, Mattick R. Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders. NDARC Monograph no. 48, 2nd edn. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Franken I H, Hendriks V M. Screening and diagnosis of anxiety and mood disorders in substance abuse patients. Am J Addict 2001; 10: 30–39
   PubMed Web of Science ®Google Scholar
• Rounsaville B J, Weissman M M, Rosenberger P H, Wilber C W, Kleber H D. Detecting depressive disorders in drug abusers. J Affect Disord 1979; 1: 255–267
   PubMed Web of Science ®Google Scholar
• Weiss R D, Griffin M L, Mirin S M. Diagnosing major depression in cocaine abusers: the use of depression rating scales. Psychiatr Res 1989; 28: 335–343
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Sheeran T, Chelminski I, Young D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat 2004; 26: 181–188
   PubMed Web of Science ®Google Scholar
• Kessler R C, Barker P R, Colpe L J, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003; 60: 184–189
   PubMed Web of Science ®Google Scholar
• Andrews G, Slade T. Interpreting scores on the Kessler psychological distress scale (K10). Aust NZ J Psychiatry 2001; 25: 494–497
   Google Scholar
• Lecrubier Y, Sheehan D V, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224–431
   Web of Science ®Google Scholar
• Spitzer R L, Kroenke K, Williams J BW. Validation and utility of a self-report version of Prime-MD: the PHQ primary care study. JAMA 1999; 282: 1737–1744
   PubMed Web of Science ®Google Scholar
• Johnson J G, Harris E S, Spitzer R L, Williams J BW. The Patient Health Questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health 2002; 30: 196–204
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W, Korten A, Jablensky A. Use of a brief screening instrument for psychosis: results of an ROC analysis. National Drug and Alcohol Research Centre, Sydney 2005, NDARC Technical Report 210
   Google Scholar
• Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001; 31: 659–668
   PubMed Web of Science ®Google Scholar
• Sheehan D V, Lecrubier Y, Sheehan K H, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997; 12: 232–241
   Web of Science ®Google Scholar
• World Health Organisation ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability, and feasibility. Addiction 2002; 97: 1183–1194
   Google Scholar
• Jorm A F, Christensen H, Griffiths K M. The public's ability to recognize mental disorders and their beliefs about treatment: changes in Australia over 8 years. Aust NZ J Psychiatry 2006; 40: 36–41
   PubMed Web of Science ®Google Scholar
• Kisely S, Scott A, Denney J, Simon G. Duration of untreated symptoms in common mental disorders: association with outcomes: international study. Br J Psychiatry 2006; 189: 79–80
   PubMed Web of Science ®Google Scholar
• Seivewright H, Tyrer P, Johnson T. Prediction of outcome in neurotic disorder: a 5-year prospective study. Psychol Med 1998; 28: 1149–1157
   Web of Science ®Google Scholar